India to Japan: Atorvastatin Export Trade Route

The India to Japan Atorvastatin corridor is one of India's established pharmaceutical export routes, with 240 shipments documented worth a combined $30.6M USD. The route is dominated by MEDREICH LIMITED, which alone accounts for roughly 38% of all export value, reflecting the consolidated nature of India's atorvastatin manufacturing sector.

Across 5 active suppliers, the average shipment value stands at $127.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 75% of all shipments, consistent with atorvastatin's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 29.7%, placing it at rank #13 among India's top atorvastatin export destinations globally.

On the import side, key buyers of Indian atorvastatin in Japan include MEIJI SEIKA PHARMATECH CO., LTD, MEIJI SEIKA PHARMA CO.LTD, ODAWARA , SAWAI PHARMACEUTICAL CO.LTD. and 13 others. MEIJI SEIKA PHARMATECH CO., LTD is the single largest importer with 53 shipments valued at $4.9M USD.

India's atorvastatin exports to Japan are driven primarily by a handful of large-scale manufacturers. MEDREICH LIMITED with 97 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Japan benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MEDREICH LIMITED, JUBILANT GENERICS LIMITED , JUBILANT GENERICS LIMITED — together account for 84% of total trade value on this route. The average shipment value of $127.7K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as atorvastatin tablets 10mg atorvastatin and atorvastatin tablets 10 mg,batch no#tv22 , suggesting that buyers in Japan tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, MEIJI SEIKA PHARMATECH CO., LTD is the largest importer with 53 shipments worth $4.9M USD — representing 16% of all atorvastatin imports from India on this route. A total of 16 buyers are active on this corridor.